Saturday, July 11, 2026

Drug profile · INN

etuvetidigene autotemcel

etuvetidigene autotemcel (WASKYRA) is an FDA-listed pharmaceutical active ingredient.

EMA: approved Blood and blood forming organs (B06) B06
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — etuvetidigene autotemcel
Class
Blood and blood forming organs (B06)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

etuvetidigene autotemcel (WASKYRA) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN etuvetidigene autotemcel
Brand WASKYRA
Therapeutic class Blood and blood forming organs (B06)
ATC code B06

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. apixaban Blood and blood forming organs (B01)
  2. berotralstat Blood and blood forming organs (B06)
  3. bivalirudin Blood and blood forming organs (B01)
  4. c1 inhibitor (human) Blood and blood forming organs (B06)
  5. clopidogrel Blood and blood forming organs (B01)
  6. dabigatran etexilate Blood and blood forming organs (B01)

Frequently asked questions

What is etuvetidigene autotemcel?

etuvetidigene autotemcel (WASKYRA) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for etuvetidigene autotemcel?

WASKYRA is a marketed brand name for etuvetidigene autotemcel. Check FDA Drugs@FDA for the current US label holder and prescribing information.